PI
TEVA icon

PEAK6 Investments’s Teva Pharmaceuticals TEVA Stock Holding History

PEAK6 Investments’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$541K Sell
30,000
-27,666
-48% -$484K ﹤0.01% 2267
2024
Q2 		$937K Buy
57,666
+2,798
+5% +$43.1K ﹤0.01% 1871
2024
Q1 		$774K Buy
54,868
+27,161
+98% +$342K ﹤0.01% 2107
2023
Q4 		$289K Buy
27,707
+12,000
+76% +$112K ﹤0.01% 2991
2023
Q3 		$160K Sell
15,707
-166,003
-91% -$1.55M ﹤0.01% 3185
2023
Q2 		$1.37M Buy
181,710
+142,520
+364% +$1.16M 0.01% 1483
2023
Q1 		$347K Sell
39,190
-40,961
-51% -$405K ﹤0.01% 2696
2022
Q4 		$731K Sell
80,151
-762,257
-90% -$6.65M ﹤0.01% 2194
2022
Q3 		$6.8M Buy
842,408
+65,139
+8% +$576K 0.03% 641
2022
Q2 		$5.85M Buy
+777,269
New +$6.77M 0.01% 1255
2022
Q1 		– Sell
-42,074
Closed -$351K – 5929
2021
Q4 		$337K Buy
42,074
+30,465
+262% +$275K ﹤0.01% 3563
2021
Q3 		$113K Sell
11,609
-621
-5% -$5.82K ﹤0.01% 4293
2021
Q2 		$121K Buy
+12,230
New +$129K ﹤0.01% 4307
2021
Q1 		– Sell
-64,379
Closed -$738K – 5525
2020
Q4 		$621K Sell
64,379
-91,824
-59% -$880K ﹤0.01% 2911
2020
Q3 		$1.41M Buy
156,203
+133,558
+590% +$1.41M ﹤0.01% 1977
2020
Q2 		$279K Sell
22,645
-130,229
-85% -$1.47M ﹤0.01% 3146
2020
Q1 		$1.37M Sell
152,874
-115,824
-43% -$1.19M 0.01% 1292
2019
Q4 		$2.63M Sell
268,698
-31,223
-10% -$279K 0.01% 936
2019
Q3 		$2.06M Sell
299,921
-248,876
-45% -$1.91M 0.01% 1251
2019
Q2 		$5.07M Buy
548,797
+307,405
+127% +$3.71M 0.03% 684
2019
Q1 		$3.79M Buy
+241,392
New +$4.26M 0.02% 878
2018
Q4 		– Sell
-130,967
Closed -$2.68M – 4651
2018
Q3 		$2.82M Buy
+130,967
New +$3.04M 0.01% 1189

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

PEAK6 Investments's TEVA Position: Q3 2024 in Review

PEAK6 Investments reduced its Teva Pharmaceuticals (TEVA) stake by 48% in Q3 2024, selling an estimated $484K and leaving 30,000 shares worth $541K. The position accounts for ﹤0.01% of the portfolio, ranked #2267.

PEAK6 Investments first reported a position in TEVA in Q3 2018 and has held it in 22 quarters since. The position peaked at $6.8M in Q3 2022. 542 funds tracked by Wall St. Rank hold TEVA as of Q3 2024.

  • PEAK6 Investments held 30,000 shares of Teva Pharmaceuticals worth $541K as of Q3 2024.
  • PEAK6 Investments sold 27,666 Teva Pharmaceuticals shares in Q3 2024, an estimated $484K.
  • Teva Pharmaceuticals made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #2267 holding.
  • PEAK6 Investments first reported a position in Teva Pharmaceuticals in Q3 2018 and has held it in 22 quarters since.
  • PEAK6 Investments's Teva Pharmaceuticals position peaked at $6.8M in Q3 2022.
  • 542 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.